Abstract:In this work, we designed and synthesized a series of amide derivatives (1-13), benzoxazine derivatives (16-28) and amino derivatives (29-30) from xyloketal B. All 28 new derivatives and seven known compounds (14, 15, 31-35) were evaluated for their protection against H2O2-induced HUVEC injury. 23 and 24 exhibited more potential protective activities than other derivatives; and the EC50 values of them and the leading compound 31 (xyloketal B) were 5.10, 3.59 and 15.97 mu M, respectively. Meanwhile, a comparative molecular similarity indices analysis (CoMSIA) was constructed to explain the structural activity relationship of these xyloketal derivatives. This 3D QSAR model from CoMSIA suggested that the derived model exhibited good predictive ability in the external test-set validation. Derivative 24 fit well with the COMSIA map, therefore it possessed the highest activity of all compounds. Compounds 23, 24 and 31 (xyloketal B) were further to examine in the JC-1 mitochondrial membrane potential (MMP) assay of HUVECs using flow cytometry (FCM). The result indicated that 23 and 24 significantly inhibited H2O2-induced decrease of the cell mitochondrial membrane potential (Delta psi m) at 25 mu M. Collectively, the protective effects of xyloketals on H2O2-induced endothelial cells may be generated from oxidation action by restraining ROS and reducing the MMP.

Design, Synthesis, and Biological Activities of Novel Ligustrazine Derivatives.

Ligustrazine Derivatives. Part 8: Design, Synthesis, and Preliminary Biological Evaluation of Novel Ligustrazinyl Amides As Cardiovascular Agents

Ligustrazine derivatives. Part 6: design, synthesis and evaluation of novel ligustrazinyl acylguanidine derivatives as potential cardiovascular agents.

Design, synthesis and biological evaluation of novel ligustrazinylated derivatives as potent cardiovascular agents

Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents.

Ligustrazine Derivatives. Part 4: Design, Synthesis, and Biological Evaluation of Novel Ligustrazine-Based Stilbene Derivatives As Potential Cardiovascular Agents

Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.

Synthesis of Novel Ligustrazine Derivatives As Potential Platelet Aggregation Inhibitors

ChemInform Abstract: Ligustrazine Derivatives. Part 5. Design, Synthesis and Biological Evaluation of Novel Ligustrazinyloxy‐Cinnamic Acid Derivatives as Potent Cardiovascular Agents.

Recent Advances in the Structural Modification of Ligustrazine and Cerebro/Cardiovascular Activity of Ligustrazine Derivatives

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Synthesis Of Ligustrazine-Aromatic Acid Derivatives And Their Inhibitory Effect On Platelet Aggregation

Structural Modification of Ligustrazine

Synthesis and Biological Evaluation of New Ligustrazine Derivatives As Anti-Tumor Agents

Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives

Design And Synthesis Of Novel Xyloketal Derivatives And Their Protective Activities Against H2o2-Induced Huvec Injury

Design and Synthesis of Ligustrazine Derivatives As Potential Anti-Alzheimer's Agents.

Synthesis of Novel Ligustrazine Derivatives As Na+/H+ Exchange Inhibitors

Synthesis of the Novel Liqustrazine Derivatives and Their Protective Effect on Injured Vascular Endothelial Cell Damaged by Hydrogen Peroxide.

Ligustrazine Monomer Against Cerebral Ischemia/ Reperfusion Injury

Novel Oxazolidinone Antibacterial Analogues with a Substituted Ligustrazine C-ring Unit.